
---
title: '呼吸道合胞病毒疫苗和单抗最新研究进展（11）'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954502'
author: 科学网
comments: false
date: Wed, 31 Aug 2022 08:12:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954502'
---

<div>   
<h1 style="margin-top:15px;margin-right:0;margin-bottom:29px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 36px"><span style="font-family:Shaker2Lancet-Bold">呼吸道合胞病毒预防制剂曙光在前</span>:　</span></strong></h1><p style="margin-top:15px;margin-right:0;margin-bottom:39px;margin-left:0;padding:0 0 0 0 "><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 36px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">疫苗和单克隆抗体百舸争流</span></span></strong></p><p style="margin-top:15px;margin-right:0;margin-bottom:39px;margin-left:0;padding:0 0 0 0 "><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">前言：</span></span></strong></p><p style="margin-top:15px;margin-right:0;margin-bottom:39px;margin-left:0;padding:0 0 0 0 "><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">　　新冠病毒大流行的将近３年，也是世界疫苗行业突飞猛进、疫苗研发技术日新月异、硕果累累的３年。疫苗制备的多种技术途径都得到深度开发，若干种新兴的技术途径如</span><span style="font-family:Microsoft YaHei UI">mRNA疫苗获得了空前的成功，在世界各地大行其道，在多种传染病以及癌症和其他慢性病的防治领域都在不断开花结果。</span></span></strong></p><p style="margin-top:15px;margin-right:0;margin-bottom:39px;margin-left:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF">　　</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">呼吸道合胞病毒（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px;background: #FFFFFF">Respiratory syncytial virus，</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">）</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">是一种历史悠久、危害极大的传染病，其疫苗的研发已经有四十年的历史，</span><span style="font-family:Microsoft YaHei UI"> 但最初开发的疫苗反而会引发</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疫苗相关性呼吸道疾病（</span><span style="font-family:Microsoft YaHei UI">VAERD，Vaccine-associated enhanced respiratory diseases</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">）</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">，即未接触过</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的儿童在接种了疫苗后，如果再接触到该病毒反而会发生更严重的</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疾病。诸如此类的问题导致针对</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的疫苗一直未能上市。乘新冠病毒疫苗大跃进的东风，已赚得盆满钵满的疫苗巨头如</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">辉瑞（</span><span style="font-family:Microsoft YaHei UI">Pfizer)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">、</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">莫德纳（</span><span style="font-family:Microsoft YaHei UI">Moderna</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">）和</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">葛兰素史克</span><span style="font-family:Microsoft YaHei UI">(GSK)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">等目前都在</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的疫苗开发上快马加鞭，有望在较短时间内取得重大突破。</span></span></strong></p><p style="margin-top:15px;margin-right:0;margin-bottom:39px;margin-left:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric"><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF">　　</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疫苗和单克隆抗体研究领域来自世界各地的顶级研究人员（约５０人）近期联名在国际著名专业杂志《</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #FF0000;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">Lancet</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI"> Infect Dis》上发表综述论文，介绍相关最新研究进展（见</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #222222;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">参考文献</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">），本博客将分数次介绍此综述的主要内容。</span></span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;background:rgb(255,255,255)"><strong><span style="font-family: Tahoma;color: #333333;letter-spacing: 0;font-size: 24px">目录：</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><span style="font-family: Tahoma;color: #333333;letter-spacing: 0;font-size: 21px">摘要</span></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><span style="font-family: Tahoma;color: #333333;letter-spacing: 0;font-size: 21px"><span style="font-family:Tahoma">一</span>.　前言</span></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><span style="font-family: Tahoma;color: #333333;letter-spacing: 0;font-size: 21px"><span style="font-family:Tahoma">二</span>.　方法</span></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><span style="font-family: Tahoma;color: #333333;letter-spacing: 0;font-size: 21px"><span style="font-family:Tahoma">三</span>.　教训（Lessons learned）</span></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><span style="font-family: Tahoma;color: #333333;letter-spacing: 0;font-size: 21px"><span style="font-family:Tahoma">四</span>.　活的减毒疫苗（liv</span><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">e attenuated vaccines</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">，</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">LAVs </span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">）</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">五</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">.</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">　嵌合疫苗（</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">Chimeric </span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">）</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">六</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">.</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">　亚单位疫苗（</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">Subunit</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">）</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">七</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">.</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">　基于颗粒的疫苗（</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">Particle-based </span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">）</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">八</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">.</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">　核酸疫苗（</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">Nucleic acid</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">）</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">九</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">.</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">　重组载体疫苗（</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">Recombinant vectors</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">）</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">十</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">.</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">　单克隆抗体（</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">MAbs</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">）</span></strong></p><p style="margin-top:31px;margin-right:0;margin-bottom:31px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:21px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">十一</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px">.</span></strong><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">　讨论</span></strong><strong><span style="font-family: Calibri;color: #333333;letter-spacing: 0;font-size: 21px"> </span></strong></p><p style="margin-top:15px;margin-right:0;margin-bottom:39px;margin-left:0;padding:0 0 0 0 "><strong><span style="font-family: Shaker2Lancet-Bold;color: #006F3C;font-size: 29px"><span style="font-family:Shaker2Lancet-Bold">七</span><span style="font-family:Shaker2Lancet-Bold">.　</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #006F3C;font-size: 29px"><span style="font-family:Shaker2Lancet-Bold">基于颗粒的疫苗</span>(Particle-based )</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">颗粒疫苗</span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">借助于颗粒组装</span><span style=";font-family:SimSun;line-height:200%;color:#231F20;font-size:20px">能充分</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">展示多种抗原的免疫原潜力。</span><span style="color: #00B050;"><strong><span style="text-decoration: underline; line-height: 200%; font-size: 20px; font-family: ScalaLancetPro;">候选疫苗</span></strong><strong><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">IVX-121</span></strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">使用一种自组装合成病毒样颗粒的平台技术，可<span style="font-family:ScalaLancetPro">传递</span>20个稳定的三聚体pre-F蛋白(DsCav-1)拷贝。计算机设计的纳米颗粒使pre-F蛋白变得非常稳定，并能在<span style="font-family:ScalaLancetPro">体外调整抗原密度。在临床前研究中，</span>IVX-121显示的中和抗体反应比单独使用DSCav1要<span style="font-family:ScalaLancetPro">高</span>10倍。第一期临床<span style="font-family:ScalaLancetPro">试验于</span>2021年开始，预计2022年能获得首批结果。在完成单<span style="font-family:ScalaLancetPro">价</span>RSV候选疫苗的试验后，该公司计划转向开发一种二价病毒样颗粒疫苗，同时包含RSV和</span><span style="text-decoration:underline;"><span style="line-height: 200%; color: #231F20; font-size: 20px; font-family: ScalaLancetPro;">人</span><span style="line-height: 200%; color: #2A2B2E; letter-spacing: 0px; font-size: 20px; background: #FFFFFF; font-family: SimSun;">偏</span><span style="line-height: 200%; color: #2A2B2E; letter-spacing: 0px; font-size: 20px; background: #FFFFFF; font-family: "Segoe UI";">肺病毒</span><span style="line-height: 200%; color: #2A2B2E; letter-spacing: 0px; font-size: 20px; background: #FFFFFF; font-family: SimSun;">（</span><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 20px">human metapneumovirus<span style="font-family:ScalaLancetPro">，HMPV</span></span></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">）抗原。</span>　</p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">第二种以颗粒为基础的</span><span style="color: #00B050;"><strong><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;"><span style="font-family: ScalaLancetPro;">候选疫苗</span>V306-VLP</span></strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">使用合成的病毒样颗粒来展示F蛋白位点2的表位。该疫苗平台使用构象受限的合成多肽与合成的<span style="font-family:ScalaLancetPro">纳米颗粒结合，合成纳米颗粒由自组装的含有</span>T辅助表位和toll样受体配体的</span><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; color: #231F20; font-size: 20px;"><span style="font-family:ScalaLancetPro">脂肽（</span> lipopeptides</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">）组成。该候选疫苗旨在进一步提高孕妇或老年人已有的免疫力。第一期临床试验正在健康女性中进行。</span><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; color: #231F20; font-size: 20px;"><span style="font-family:ScalaLancetPro">经皮贴片（</span> epicutaneous patch<span style="font-family:ScalaLancetPro">）</span></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">的无针皮内给药途径正在探索用于加强接种，在一期临床试验中显示百日咳疫苗的抗体滴度与现用商业疫苗的结果相似，但可能需要采用增强的给药程序以优化疫苗接种。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">总体而言，</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">基于</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">颗粒</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">的</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">疫苗</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">目前</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">仍处于早期开发阶段，但有可能对孕妇和老年人产生强大的免疫反应。</span></p><p style="margin-top:15px;margin-right:0;margin-bottom:39px;margin-left:0;padding:0 0 0 0 "><strong><span style="font-family: Shaker2Lancet-Bold;color: #006F3C;font-size: 29px"><span style="font-family:Shaker2Lancet-Bold">八</span>.　核酸疫苗（Nucleic acid）</span></strong><span style="font-family: Calibri; font-size: 20px; text-indent: 43px;"> </span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="color: #00B050;"><strong><span style="font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">mRNA疫苗已经显示出对</span><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">SARS-CoV-2<span style="font-family: ScalaLancetPro;">（新冠病毒</span></span><span style="font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">）感染的安全性和高效性，该疫苗其实正<span style="font-family: ScalaLancetPro;">是基于之前对</span></span><span style="font-family: ScalaLancetPro; line-height: 200%; font-size: 20px; text-decoration: underline; color: #FF0000;">RSV 的mRNA疫苗</span><span style="font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">研究的经验而开发的。</span></strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">正是由于有将RSV的</span><span style="font-family: ScalaLancetPro; line-height: 200%; color: #231F20; font-size: 20px; text-decoration: underline;"><strong> pre-F（前融合蛋白）</strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">用作疫苗抗原的成功经验<span style="font-family:ScalaLancetPro">，两种</span>COVID-19mRNA 疫苗才都直接选用</span><span style="font-family: ScalaLancetPro; line-height: 200%; color: #231F20; font-size: 20px; text-decoration: underline;">表达稳定版本的SARS-CoV-2 pre-F刺突蛋白</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">。最初开发的RSV疫苗会引发</span><strong><span style="text-decoration: underline; line-height: 200%; color: #231F20; font-size: 20px; font-family: ScalaLancetPro;">疫苗相关性呼吸道疾病（VAERD，Vaccine-associated enhanced respiratory diseases）</span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">，如何避免RSV疫苗相关的呼吸道疾病增强作用的广泛研究<span style="font-family:ScalaLancetPro">对快速开发</span>COVID-19疫苗也很重要，并为疫苗安全性提供了监管指南。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="color: #FF0000; font-size: 24px;"><strong><span style="color: #FF0000; font-family: ScalaLancetPro; line-height: 200%;"><span style="color: #FF0000; font-family: ScalaLancetPro;">由于成功地扩大规模并建立了稳健的供应链，</span>mRNA将成为一种新的疫苗模式，可用于其他目标<span style="color: #FF0000; font-family: ScalaLancetPro;">，包括</span>RSV疫苗。</span></strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">一种</span><span style="color: #00B050;"><strong><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">mRNA疫苗(mRNA-1345)</span></strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px"><span style="font-family:ScalaLancetPro">编码稳定的</span>RSV pre-F，使用与SARS-CoV-2疫苗SpikeVax (Moderna)相同的脂质纳米颗粒配方，已知SpikeVax可以诱导和增强抗体和T细胞反应，包括CD8+ T细胞、Th1细胞和T滤泡（follicular）辅助细胞。在年轻人和老年人中进行的一期临床试验的中期结果，显示了良好的安全性和对中和活性的有效促进。2/3期临床<span style="font-family:ScalaLancetPro">试验</span>(ConquerRSV)于2021年11月17日开始，共有34000名60岁以上的成年人参加。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">该公司还打算将</span><span style="color: #00B050;"><strong><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">mRNA-1345</span></strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">与</span><span style="color: #00B050;"><strong><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; font-size: 20px;">mRNA-1653</span></strong></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">(一种针对另外两种儿童病毒的mRNA疫苗：</span><span style="text-decoration:underline;"><span style="line-height: 200%; color: #231F20; font-size: 20px; font-family: ScalaLancetPro;">人</span><span style="line-height: 200%; color: #2A2B2E; letter-spacing: 0px; font-size: 20px; background: #FFFFFF; font-family: SimSun;">偏</span><span style="line-height: 200%; color: #2A2B2E; letter-spacing: 0px; font-size: 20px; background: #FFFFFF; font-family: "Segoe UI";">肺病毒</span></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">和</span><strong><span style="text-decoration: underline; font-family: ScalaLancetPro; line-height: 200%; color: #231F20; font-size: 20px;"><span style="font-family:ScalaLancetPro">副流感病毒</span>3型</span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:20px">)结合使用。1期临床试验(NCT04144348)正在育龄妇女和血清阳性儿童中进行。</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">（未完待续）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 24px">参考文献：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">Natalie I Mazur,</span></em><em>　</em><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">et al., </span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">Respiratory syncytial virus prevention within reach:</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"> the vaccine and monoclonal antibody landscape, </span></strong><em><span style="font-family: Shaker2Lancet-Bold;color: #FF0000;letter-spacing: 0;font-size: 20px">Lancet Infect Dis</span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"><span style="font-family:Shaker2Lancet-Bold">，</span> Published online August 8, 2022， </span></strong><span style="font-family: Tahoma;color: #505050;letter-spacing: 0;font-size: 20px">DOI: </span><a href="https://doi.org/10.1016/S1473-3099(22)00291-2" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 20px">https://doi.org/10.1016/S1473-3099(22)00291-2</span></a><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 20px">，</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #6666CC;letter-spacing: 0;font-size: 20px">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext</span></span></a><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">.</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px">相关博文：</span></strong><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"></a></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954502" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（１）</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 20px"> 2022-08-12</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350986" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954501" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>2）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-13</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"></a><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954500" title alt="image.png" referrerpolicy="no-referrer"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>3）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-15</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351490" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>4）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-17</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351871" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>5）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-20</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352158" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>6）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-22</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352448" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954499" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>7）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-24</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352713" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954498" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>8）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-26</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954497" title alt="image.png" referrerpolicy="no-referrer"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352981" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>9）</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-28</span></p><p style="margin: 16px 0px; text-indent: 0px; padding: 0px; line-height: 28px; background: rgb(255, 255, 255);"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1353081" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=954495" title alt="image.png" referrerpolicy="no-referrer"><strong><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>10）</span></strong></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-29</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1353361.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1353361.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1353081.html" target="_black">呼吸道合胞病毒疫苗和单抗最新研究进展（10）</a><br>                    <!--大赛结束-->
                                        
  
</div>
            